Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-8 of 8 for your search:
Drug:
clarithromycin
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Observation Versus Chlorambucil After Anti-Helicobacter Therapy in Patients With Low Grade (Stage I) Gastric Lymphoma
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
16 and over
Sponsor:
Protocol IDs:
BNLI-LY03
, EU-98040, NCT00003617
2.
Phase II Study of Antibiotics and Gastric Acid Inhibition for Gastric MALT Lymphoma (Summary Last Modified 11/2000)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 80
Sponsor:
NCI
Protocol IDs:
MDA-CPPDM-95084
, NCI-T95-0003D, NCT00002682, T95-0003
3.
Phase II Trial of Antibiotic Eradication of Helicobacter Pylori and, Failing That, Local Therapy with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) and Involved Field Radiation in Patients with Mucosa Associated Lymphoid Tissue (MALT) Lymphomas (Summary Last Modified 04/1999)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
SWOG-9703
, S9703
4.
Phase II Study of Anti-Helicobacter pylori Treatment in Endoscopically Diagnosed Low Grade Localized Gastric Lymphoma (Summary Last Modified 05/2000)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
EORTC-20961
, CRC-EORTC-20961, HOVON-33, NCT00003151
5.
Phase II Randomized Chemoprevention Study of Dehydroepiandrosterone (DHEA) Versus Clarithromycin in Patients With Monoclonal Gammopathy of Undetermined or Borderline Significance
Phase:
Phase II
Type:
Prevention
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-979202
, NCI-P00-0163, NCT00006219
6.
Phase II Study of Maintenance Therapy Comprising Thalidomide, Dexamethasone, and Clarithromycin in Patients With Multiple Myeloma Who Have Undergone Prior Autologous or Syngeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
Not specified
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
FHCRC-1767.00
, 5589, CELGENE-FHCRC-1767.00, NCT00182663
7.
Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
0904-501
, NCT00151203
8.
Phase II Study of Maintenance Therapy Comprising Lenalidomide, Dexamethasone, and Clarithromycin in Patients Who Have Undergone Autologous or Syngeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
FHCRC-2135.00
, 6435, NCT00445692
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute